Enhanced microbubble contrast agent oscillation following 250 kHz insonation

Abstract Microbubble contrast agents are widely used in ultrasound imaging and therapy, typically with transmission center frequencies in the MHz range. Currently, an ultrasound center frequency near 250 kHz is proposed for clinical trials in which ultrasound combined with microbubble contrast agent...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tali Ilovitsh, Asaf Ilovitsh, Josquin Foiret, Charles F. Caskey, Jiro Kusunose, Brett Z. Fite, Hua Zhang, Lisa M. Mahakian, Sarah Tam, Kim Butts-Pauly, Shengping Qin, Katherine W. Ferrara
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/19ed9eca82bc4b5cb7a1622cc7c40e6a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:19ed9eca82bc4b5cb7a1622cc7c40e6a
record_format dspace
spelling oai:doaj.org-article:19ed9eca82bc4b5cb7a1622cc7c40e6a2021-12-02T15:07:51ZEnhanced microbubble contrast agent oscillation following 250 kHz insonation10.1038/s41598-018-34494-52045-2322https://doaj.org/article/19ed9eca82bc4b5cb7a1622cc7c40e6a2018-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-34494-5https://doaj.org/toc/2045-2322Abstract Microbubble contrast agents are widely used in ultrasound imaging and therapy, typically with transmission center frequencies in the MHz range. Currently, an ultrasound center frequency near 250 kHz is proposed for clinical trials in which ultrasound combined with microbubble contrast agents is applied to open the blood brain barrier, since at this low frequency focusing through the human skull to a predetermined location can be performed with reduced distortion and attenuation compared to higher frequencies. However, the microbubble vibrational response has not yet been carefully evaluated at this low frequency (an order of magnitude below the resonance frequency of these contrast agents). In the past, it was assumed that encapsulated microbubble expansion is maximized near the resonance frequency and monotonically decreases with decreasing frequency. Our results indicated that microbubble expansion was enhanced for 250 kHz transmission as compared with the 1 MHz center frequency. Following 250 kHz insonation, microbubble expansion increased nonlinearly with increasing ultrasonic pressure, and was accurately predicted by either the modified Rayleigh–Plesset equation for a clean bubble or the Marmottant model of a lipid-shelled microbubble. The expansion ratio reached 30-fold with 250 kHz at a peak negative pressure of 400 kPa, as compared to a measured expansion ratio of 1.6 fold for 1 MHz transmission at a similar peak negative pressure. Further, the range of peak negative pressure yielding stable cavitation in vitro was narrow (~100 kPa) for the 250 kHz transmission frequency. Blood brain barrier opening using in vivo transcranial ultrasound in mice followed the same trend as the in vitro experiments, and the pressure range for safe and effective treatment was 75–150 kPa. For pressures above 150 kPa, inertial cavitation and hemorrhage occurred. Therefore, we conclude that (1) at this low frequency, and for the large oscillations, lipid-shelled microbubbles can be approximately modeled as clean gas microbubbles and (2) the development of safe and successful protocols for therapeutic delivery to the brain utilizing 250 kHz or a similar center frequency requires consideration of the narrow pressure window between stable and inertial cavitation.Tali IlovitshAsaf IlovitshJosquin FoiretCharles F. CaskeyJiro KusunoseBrett Z. FiteHua ZhangLisa M. MahakianSarah TamKim Butts-PaulyShengping QinKatherine W. FerraraNature PortfolioarticleMicrobubbles (MBs)Inertial CavitationStable CavitationMarmottant ModelExpansion RatioMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-15 (2018)
institution DOAJ
collection DOAJ
language EN
topic Microbubbles (MBs)
Inertial Cavitation
Stable Cavitation
Marmottant Model
Expansion Ratio
Medicine
R
Science
Q
spellingShingle Microbubbles (MBs)
Inertial Cavitation
Stable Cavitation
Marmottant Model
Expansion Ratio
Medicine
R
Science
Q
Tali Ilovitsh
Asaf Ilovitsh
Josquin Foiret
Charles F. Caskey
Jiro Kusunose
Brett Z. Fite
Hua Zhang
Lisa M. Mahakian
Sarah Tam
Kim Butts-Pauly
Shengping Qin
Katherine W. Ferrara
Enhanced microbubble contrast agent oscillation following 250 kHz insonation
description Abstract Microbubble contrast agents are widely used in ultrasound imaging and therapy, typically with transmission center frequencies in the MHz range. Currently, an ultrasound center frequency near 250 kHz is proposed for clinical trials in which ultrasound combined with microbubble contrast agents is applied to open the blood brain barrier, since at this low frequency focusing through the human skull to a predetermined location can be performed with reduced distortion and attenuation compared to higher frequencies. However, the microbubble vibrational response has not yet been carefully evaluated at this low frequency (an order of magnitude below the resonance frequency of these contrast agents). In the past, it was assumed that encapsulated microbubble expansion is maximized near the resonance frequency and monotonically decreases with decreasing frequency. Our results indicated that microbubble expansion was enhanced for 250 kHz transmission as compared with the 1 MHz center frequency. Following 250 kHz insonation, microbubble expansion increased nonlinearly with increasing ultrasonic pressure, and was accurately predicted by either the modified Rayleigh–Plesset equation for a clean bubble or the Marmottant model of a lipid-shelled microbubble. The expansion ratio reached 30-fold with 250 kHz at a peak negative pressure of 400 kPa, as compared to a measured expansion ratio of 1.6 fold for 1 MHz transmission at a similar peak negative pressure. Further, the range of peak negative pressure yielding stable cavitation in vitro was narrow (~100 kPa) for the 250 kHz transmission frequency. Blood brain barrier opening using in vivo transcranial ultrasound in mice followed the same trend as the in vitro experiments, and the pressure range for safe and effective treatment was 75–150 kPa. For pressures above 150 kPa, inertial cavitation and hemorrhage occurred. Therefore, we conclude that (1) at this low frequency, and for the large oscillations, lipid-shelled microbubbles can be approximately modeled as clean gas microbubbles and (2) the development of safe and successful protocols for therapeutic delivery to the brain utilizing 250 kHz or a similar center frequency requires consideration of the narrow pressure window between stable and inertial cavitation.
format article
author Tali Ilovitsh
Asaf Ilovitsh
Josquin Foiret
Charles F. Caskey
Jiro Kusunose
Brett Z. Fite
Hua Zhang
Lisa M. Mahakian
Sarah Tam
Kim Butts-Pauly
Shengping Qin
Katherine W. Ferrara
author_facet Tali Ilovitsh
Asaf Ilovitsh
Josquin Foiret
Charles F. Caskey
Jiro Kusunose
Brett Z. Fite
Hua Zhang
Lisa M. Mahakian
Sarah Tam
Kim Butts-Pauly
Shengping Qin
Katherine W. Ferrara
author_sort Tali Ilovitsh
title Enhanced microbubble contrast agent oscillation following 250 kHz insonation
title_short Enhanced microbubble contrast agent oscillation following 250 kHz insonation
title_full Enhanced microbubble contrast agent oscillation following 250 kHz insonation
title_fullStr Enhanced microbubble contrast agent oscillation following 250 kHz insonation
title_full_unstemmed Enhanced microbubble contrast agent oscillation following 250 kHz insonation
title_sort enhanced microbubble contrast agent oscillation following 250 khz insonation
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/19ed9eca82bc4b5cb7a1622cc7c40e6a
work_keys_str_mv AT taliilovitsh enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation
AT asafilovitsh enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation
AT josquinfoiret enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation
AT charlesfcaskey enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation
AT jirokusunose enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation
AT brettzfite enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation
AT huazhang enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation
AT lisammahakian enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation
AT sarahtam enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation
AT kimbuttspauly enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation
AT shengpingqin enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation
AT katherinewferrara enhancedmicrobubblecontrastagentoscillationfollowing250khzinsonation
_version_ 1718388368957505536